Atomic level analysis has revealed how two classes of calcium channel blockers, widely prescribed for heart disease patients, produce separate therapeutic effects by acting at different sites on the ...

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood. Researchers at the University of Bristol have ...

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood. Researchers at the University of Bristol have ...

Myotonic dystrophy is one of the most common forms of muscular dystrophy. It is a genetic condition that causes progressive muscle weakness and wasting. No treatments currently exist that slow the ...

An atomic level analysis has revealed how two classes of calcium channel blockers, widely prescribed for heart disease patients, produce separate therapeutic effects through their actions at different ...

March 14, 2005 (Orlando) -- Calcium channel blockers and angiotensin-converting enzyme (ACE) inhibitors are a more effective combination for treating hypertension than beta-blockers and diuretics, ...

Calcium channel blockers are a class of drugs prescribed for high blood pressure and other heart diseases. The medications reduce blood pressure by helping blood vessels to relax. Calcium channel ...

When you have atrial fibrillation, the two upper chambers of your heart (atria) don't beat in sync with the two lower chambers (ventricles). This makes your heart beat out of rhythm and sometimes very ...

How Should I Take Them? Calcium channel blockers should be taken with food or milk. Follow the label directions on how often to take it. The number of doses you take each day, the time allowed between ...

Dear Dr. Roach: Does taking Norvasc or any calcium channel blocker reduce or destroy the calcium in the bones, eventually causing osteoporosis? — E.G. Answer: No. Calcium channel blockers, like ...

Active ingredient: Clevidipine butyrate emulsion 0.5 mg/mL; solution for IV infusion; contains lipids 0.2 g/mL (soybean oil, egg phospholipids). Indication: To reduce BP when oral therapy is not ...